Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Intangibles (2023 - 2024)

Historic Change in Intangibles for Mirum Pharmaceuticals (MIRM) over the last 2 years, with Q3 2024 value amounting to $10.0 million.

  • Mirum Pharmaceuticals' Change in Intangibles changed N/A to $10.0 million in Q3 2024 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of $20.0 million for FY2024, which is 0.0% changed from last year.
  • Mirum Pharmaceuticals' Change in Intangibles amounted to $10.0 million in Q3 2024.
  • Over the past 5 years, Mirum Pharmaceuticals' Change in Intangibles peaked at $15.0 million during Q1 2023, and registered a low of $5.0 million during Q4 2023.